Get the app!
Back to Companies

Arbutus Biopharma Corp

ABUSNasdaqCIK: 0001447028

Over the 15 most recent insider filings, Arbutus Biopharma Corp (ABUS) has seen activity from 5 distinct insiders — no open-market buying or selling. Roivant Sciences Ltd. is the most active by dollar volume, and the single largest transaction was $44.8M by Roivant Sciences Ltd.. All figures are drawn from official SEC Form 3, 4, and 5 disclosures and update as new filings arrive.

Total Volume
$52.8M
Purchases
$0
Sales
$0
Unique Insiders
5

Recent Insider Trades

15 loaded
Oct 7ABUS
Arbutus Biopharma Corp
Sawhney RogerDirectorDisposed$85.7K
Oct 7ABUS
Arbutus Biopharma Corp
Nguyen TuanChief Financial OfficerDisposed$240.4K
Oct 7ABUS
Arbutus Biopharma Corp
Androski LindsayPresident and CEO, DirectorDisposed$123.3K
Oct 5[ABUS]
Arbutus Biopharma Corp
Roivant Sciences Ltd.InsiderDisposed$44.8M
Oct 7ABUS
Arbutus Biopharma Corp
Beardsley Robert ADirectorDisposed$89.7K
Sep 23ABUS
Arbutus Biopharma Corp
Androski LindsayPresident and CEO, DirectorExercise$1.3M
Sep 23ABUS
Arbutus Biopharma Corp
Nguyen TuanChief Financial OfficerExercise$3.1M
Sep 23ABUS
Arbutus Biopharma Corp
Beardsley Robert ADirectorExercise$1.5M
Sep 23ABUS
Arbutus Biopharma Corp
Sawhney RogerDirectorExercise$1.5M
Jun 10ABUS
Arbutus Biopharma Corp
Beardsley Robert ADirectorAward$0
Jun 10ABUS
Arbutus Biopharma Corp
Sawhney RogerDirectorAward$0
Feb 2ABUS
Arbutus Biopharma Corp
Nguyen TuanChief Financial OfficerGrant$0
Feb 2ABUS
Arbutus Biopharma Corp
Androski LindsayPresident and CEO, DirectorGrant$0
Aug 6ABUS
Arbutus Biopharma Corp
Sawhney RogerDirectorOther$0
Aug 6ABUS
Arbutus Biopharma Corp
Sawhney RogerDirectorAward$0

15 filings